SCHEMBL14136369

SCHEMBL14136369

CN1CCC(c2nc3cc(C(F)(F)F)ccc3o2)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
RAB9A P51151 2/20 0.45
NPC1 O15118 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
LMNA P02545 3/20 0.44
THRB P10828 2/20 0.44
HRH4 Q9H3N8 1/20 0.42
MPO P05164 1/20 0.41
HTR6 P50406 1/20 0.40
KCNH2 Q12809 1/20 0.40
HTR3E A5X5Y0 1/20 0.40
KDM4E B2RXH2 1/20 0.40
HTR3B O95264 1/20 0.40
TP53 P04637 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HTR1A P08908 1/20 0.40
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2709039 0.82 MPO (0.59) ALDH1A1RAB9ANPC1SMN1; SMN2HRH4
SCHEMBL24473794 0.82 RAB9A (0.50) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL14136368 0.81 RAB9A (0.49) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL20304443 0.80 RAB9A (0.48) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL29780578 0.80 RAB9A (0.48) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL6125251 0.78 LMNA (0.53) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL10267105 0.77 USP30 (0.47) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL14555090 0.77 MPO (0.47) ALDH1A1RAB9ANPC1SMN1; SMN2LMNA
SCHEMBL13810503 0.76 LMNA (0.61) ALDH1A1LMNATHRBTP53USP2
SCHEMBL10901812 0.76 MAOA (0.43) ALDH1A1HRH4KCNH2CYP2D6HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1950199-A1 Proline derivatives and use thereof as drugs Mitsubishi Tanabe Pharma Corporation (JP) 2008-07-30 EP disclosed